Clinical Trials Directory

Trials / Completed

CompletedNCT03256903

Methoxyflurane vs Standard Analgesic Treatment for Trauma Pain in Spanish Emergency Units

Open Randomized Clinical Trial to Compare Pain Relief Between Methoxyflurane and Standard of Care for Treating Patients With Trauma Pain in Spanish Emergency Units.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
310 (actual)
Sponsor
Mundipharma Pharmaceuticals S.L. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Clinical trial to compare pain relief between methoxyflurane and any analgesic treatment used in usual clinical practice, in patients with trauma and associated pain, treated in Spanish emergency units.

Detailed description

Open, randomized clinical trial to compare emergency pain relief between methoxyflurane and standard of care in patients with trauma and associated pain, treated in Spanish emergency units. Methoxyflurane is a fluorinated ethyl methyl ether, with the chemical name 2:2-dichloro-1:1-difluoroethyl methyl ether. It belongs to the fluorinated hydrocarbon group of volatile anaesthetics. It is inhaled as a vapour at low (sub-anaesthetic) concentrations to achieve an analgesic effect for the management of pain. In Europe countries, where methoxyflurane is already marketed, it is indicated for emergency relief of moderate to severe pain in conscious adult patients with trauma and associated pain. On the other hand, current clinical practice includes a variety of analgesic agents, with the choice of which to employ based on consideration of the risk-benefit factors of each class of drug, as well as the type of pain, its severity, and the risk of adverse effects. The main objective of this study is to assess Methoxyflurane's significant advantage in terms of anaglesic effectiveness, as it is known as a rapidly acting, non-narcotic analgesic for the treatment of emergency pain.

Conditions

Interventions

TypeNameDescription
DRUGMethoxyfluraneUp to two inhalers containing 3 mL methoxyflurane. Treatment duration: 1 administration in 1 day.
DRUGStandard of careAny kind of analgesia, administered by any route for emergency relief of moderate to severe pain in conscious adult patients with trauma and associated pain

Timeline

Start date
2017-07-07
Primary completion
2018-03-06
Completion
2018-07-31
First posted
2017-08-22
Last updated
2018-08-20

Locations

14 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT03256903. Inclusion in this directory is not an endorsement.